Lifecore Biomedical Inc (NASDAQ: LFCR) stock closed at $7.05 on 9/24/25 after a major decline of -10.7%. Moreover, exceptionally high trading volume at 372% of normal accompanied the decline. The stock has declined -10.2% during the last week but has been strong relative to the market over the last nine months.
Current PriceTarget Research Rating
Lifecore Biomedical has a current Value Trend Rating of D (Negative). This rating combines very contradictory signals from two proprietary PTR measures of a stock’s attractiveness. Lifecore Biomedical has a very low Appreciation Score of 0 but a good Power Rating of 80, leading to the Negative Value Trend Rating.
Rating Review
In light of this highly negative price change we are reviewing our current Overall Rating of D. This review will be completed in the next several days.
Be the first to comment